Synergistic anti-liver fibrosis actions of total astragalus saponins and glycyrrhizic acid via TGF-β1/Smads signaling pathway modulation
Authors:
- 1 August 2016
- journal article
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 190, 83-90
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81273728)
This publication has 12 references indexed in Scilit:
- Transcriptomic analysis of the effects of Toll-like receptor 4 and its ligands on the gene expression network of hepatic stellate cellsFibrogenesis & Tissue Repair, 2016
- Astragaloside prevents BDL-induced liver fibrosis through inhibition of notch signaling activationJournal of Ethnopharmacology, 2015
- Animal Models for Fibrotic Liver Diseases: What We Have, What We Need, and What Is under DevelopmentJournal of Clinical and Translational Hepatology, 2015
- Liver fibrosis and repair: immune regulation of wound healing in a solid organNature Reviews Immunology, 2014
- Functional linkage of cirrhosis‐predictive single nucleotide polymorphisms of toll‐like receptor 4 to hepatic stellate cell responses†‡Hepatology, 2009
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Biochemical and histological effects of 26 weeks of glycyrrhizin treatment in chronic hepatitis C: A randomized phase II trialJournal of Hepatology, 2006
- Liver fibrosisJournal of Clinical Investigation, 2005
- Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5)Journal of Medicinal Chemistry, 2002
- A simple method to determine nanogram levels of 4-hydroxyproline in biological tissuesAnalytical Biochemistry, 1981